중동 및 아프리카 q-PCR 시약 시장 – 2029년까지의 산업 동향 및 예측

TOC 요청 TOC 요청 분석가에게 문의 분석가에게 문의 지금 구매 지금 구매 구매하기 전에 문의 구매하기 전에 문의 무료 샘플 보고서 무료 샘플 보고서

중동 및 아프리카 q-PCR 시약 시장 – 2029년까지의 산업 동향 및 예측

  • Pharmaceutical
  • Published Report
  • Jan 2022
  • MEA
  • 350 Pages
  • 테이블 수: 123
  • 그림 수: 52

중동 및 아프리카 q-PCR 시약 시장, 검출 유형(염료 기반 시약 및 프로브 기반 시약), 분석 유형(Qpcr 싱글플렉스 검사/분석 및 Qpcr 멀티플렉스 검사/분석), 플렉시티(염료 기반 시약 및 프로브 기반 시약), 포장 유형(키트 및 마스터 믹스), 기술(유전자 발현, 유전자 타이핑, MIRNA 분석, 사전 증폭 및 바이러스 검출), 응용 분야(진단, 연구 및 법의학), 최종 사용자(병원 및 진단 센터, 법의학 연구소, 연구 및 학술 기관, 임상 연구 기관 및 기타), 유통 채널(직접 입찰, 제3자 유통업체 및 기타), 국가(사우디 아라비아, UAE, 이스라엘, 이집트, 남아프리카 공화국 및 쿠웨이트, 중동 및 아프리카의 나머지 지역) 산업 동향 및 2029년까지의 예측.

중동 및 아프리카 q-PCR 시약 시장

시장 분석 및 통찰력 : 중동 및 아프리카 q-PCR 시약 시장 

중동 및 아프리카 q-PCR 시약 시장은 2022년에서 2029년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년에서 2029년의 예측 기간 동안 4.3%의 CAGR로 성장하고 있으며 2029년까지 2,952만 달러에 도달할 것으로 예상한다고 분석합니다. 가처분 소득 증가와 신제품 개발 증가는 예측 기간 동안 시장 수요를 촉진한 주요 원동력입니다. 그러나 팬데믹 동안 제한이 증가하면서 시장이 제약을 받고 있습니다.

q-PCR 시약은 샘플에서 알려진 시퀀스의 절대적 또는 상대적 양을 결정하는 데 도움이 되며 법의학, 연구, 진단과 같은 다양한 응용 분야에 사용됩니다.

q-PCR 시약에 대한 수요는 선진국과 개발도상국 모두에서 증가했으며, 그 이유는 노령 인구의 증가와 제품 출시 때문입니다. q-PCR 시약 시장은 혁신적인 제품의 도입, 기술 제품의 증가, 가처분 소득의 증가로 인해 성장하고 있습니다. 시장은 신흥 시장 탐색, 시장 참여자의 전략적 이니셔티브, 의료비 지출 증가로 인해 예측 기간 동안 성장할 것입니다.

다양한 주요 시장 참여자의 존재는 시장이 성장할 수 있는 기회를 제공하는 반면, 숙련된 전문가의 부족은 마커가 성장하기 어려운 문제입니다. q-PCR 시약은 샘플에서 알려진 시퀀스의 절대적 또는 상대적 양을 결정하는 데 도움이 되며 법의학, 연구 및 진단과 같은 다양한 응용 분야에서 사용됩니다.

q-PCR 시약 시장 보고서는 시장 점유율, 새로운 개발, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 기회 분석에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.

중동 및 아프리카 q-PCR 시약 시장

Middle East & Africa q-PCR reagents Market Scope and Market Size

Q-PCR reagents market is segmented on the basis of eight notable segment which is detection type, assay type, plexity, packaging type, application, technology, end user and distribution channel.

  • On the basis of detection type, Middle East and Africa q-PCR reagents market is segmented into dye -based reagents and probe -based reagents. In 2022, probe-based reagents segment is expected to dominate the Middle East and Africa q-PCR reagent market due to increasing healthcare expenditure.
  • On the basis of assay type, Middle East and Africa q-PCR reagents market is segmented into qPCR singleplex test/assay and qPCR multiplex test/assay. In 2022, qPCR singleplex test/assay segment is expected to dominate the Middle East and Africa q-PCR reagent market due to the presence of major market players.
  • On the basis of plexity, Middle East and Africa q-PCR reagents market is segmented into dye -based reagents and probe -based reagents. In 2022, dye-based reagents segment is expected to dominate the Middle East and Africa q-PCR reagent market due to advanced technologies and product launch.
  • On the basis of packaging type, Middle East and Africa q-PCR reagents market is segmented into kits and master mixes. In 2022, kits are boosting market growth due to increasing private-public finance for life science and research.
  • On the basis of technology, Middle East and Africa q-PCR reagents market is segmented into gene expression, gene typing, MIRNA analysis, pre-amplification and virus detection. In 2022, the gene expression segment is expected to dominate the market owing to the increase in demand of Q-PCR reagents for diagnostics.
  • On the basis of application, Middle East and Africa q-PCR reagents market is segmented into diagnostics, research and forensic. In 2022, the forensic application is expected to grow at the fastest rate in the market due to mounting frequencies of criminal cases in Middle East and African countries.
  • On the basis of end user, Middle East and Africa q-PCR reagents market is segmented into hospital & diagnostic centers, forensic laboratories, research & academic institute, clinical research organization, pharmaceutical and biopharmaceutical companies and others. In 2022, the hospital & diagnostic centers segment is expected to dominate the market due to the increase in early diagnostic.
  • On the basis of distribution channel, Middle East and Africa q-PCR reagents market is segmented into direct tender third party distributors and others. In 2022, direct tender is expected to dominate the Middle East and Africa q-PCR reagents market as direct tender is an easy process does not involve any other medium for supply.

Q-PCR Reagents Market Country Level Analysis

The q-PCR reagents market is analyzed and market size information is provided on the basis of country, detection type, assay type, plexity, packaging type, application, technology, end user and distribution channel.

The countries covered in the q-PCR reagents market report are the South Africa, Israel, Egypt, Kuwait, U.A.E Saudi Arab, and rest of Middle East and Africa.

q-PCR reagents segmenting Middle East and Africa region is expected to grow with the highest growth rate in the forecast period of 2022 to 2029 because of increasing number of q-PCR reagents manufacturers and R&D activities. South Africa is leading the growth of the Middle East and Africa q-PCR reagents market and cardiovascular segment is dominating in this country due to increase in incidence of disease in the region.

The country section of the report also provides individual market affecting factors and changes in regulation in the market domestically that affects the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Middle East & Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Rising New Product Development are Boosting the Market Growth of q-PCR Reagents

q-PCR reagents market also provides you with detailed market analysis for every country growth in q-PCR reagents industry with q-PCR reagents drugs sales, impact of advancement in the q-PCR reagents technology and changes in regulatory scenarios with their support for the q-PCR reagents market. The data is available for historic period 2010 to 2019.

Competitive Landscape and q-PCR Reagents Market Share Analysis

q-PCR reagents market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to q-PCR reagents market.

The major companies, which are dealing in the Middle East and Africa q-PCR reagents market, are Agilent Technologies, Inc, Biotium, MiRXES Pte Ltd, GeneDireX, Inc, F. Hoffmann-La Roche Ltd, Norgen Biotek Corp, Takara Holdings Inc., Enzo Biochem Inc, Qiagen, PCR Biosystems, Tonbo Biosciences, Quantabio, and Merck KgAA among others.

The companies’ also initiate many product launch and agreement worldwide, which are also accelerating the q-PCR reagents market.

For instance,

  • In July 2020, New England Biolabs announced that they have extended its global subsidiary network with the opening of New England Biolabs Australia Pty Ltd. This has increased company’s product reach and distribution channel
  • 2020년 4월, Empirical Bioscience Inc.는 QuantiTASE 및 QuantiTASE PLUS One Step RT-qPCR RT-qPCR 키트가 CDC 테스트 프로토콜에 따라 EUA 승인 qPCR 검출 키트를 사용한 분석에서 성공적으로 테스트되었다고 발표했습니다. 이를 통해 회사의 제품 포트폴리오가 증가했습니다.

협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략은 q-PCR 시약 시장에서 회사 시장을 강화하고 있으며, 이를 통해 기업이 q-PCR 시약에 대한 제공을 개선하는 데에도 도움이 됩니다.


SKU-

세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요

  • 대화형 데이터 분석 대시보드
  • 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
  • 사용자 정의 및 질의를 위한 리서치 분석가 액세스
  • 대화형 대시보드를 통한 경쟁자 분석
  • 최신 뉴스, 업데이트 및 추세 분석
  • 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
데모 요청

목차

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 DETECTION TYPE LIFELINE CURVE

2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.9 DBMR MARKET POSITION GRID

2.1 MARKET APPLICATION COVERAGE GRID

2.11 VENDOR SHARE ANALYSIS

2.12 SECONDARY SOURCES

2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 INDUSTRIAL INSIGHTS

5.1 PESTEL ANALYSIS

5.2 PORTER'S FIVE FORCES MODEL

6 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: REGULATIONS

6.1 REGULATION IN U.S

6.2 REGULATION IN EUROPE

6.3 REGULATION IN SINGAPORE

6.4 REGULATION IN AUSTRALIA

7 MARKET OVERVIEW

7.1 DRIVERS

7.1.1 INCREASE IN CHRONIC DISEASES AND COMMUNICABLE DISEASES

7.1.2 INCREASE IN GERIATRIC POPULATION

7.1.3 INCREASE IN EARLY DIAGNOSIS RATE

7.1.4 INCREASE IN ADVANCED TECHNOLOGY

7.2 RESTRAINTS

7.2.1 STRINGENT RULES & REGULATIONS

7.2.2 HIGH COST OF PRODUCT

7.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS

7.2.4 ADVANCEMENT IN FIELD OF GENOMICS

7.3 OPPORTUNITIES

7.3.1 RISE IN GOVERNMENT FUNDING FOR HEALTHCARE

7.3.2 RISE IN HEALTHCARE EXPENDITURE

7.4 CHALLENGES

7.4.1 LACK OF SKILLED WORKFORCE

7.4.2 OPERATIONAL BARRIERS FACED IN CONDUCTING DIAGNOSTIC TESTS

8 IMPACT OF COVID-19 ON THE MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET

8.1 IMPACT ON PRICE

8.2 IMPACT ON DEMAND

8.3 IMPACT ON SUPPLY CHAIN

8.4 STRATEGIC DECISIONS BY MANUFACTURERS

8.5 CONCLUSION

9 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE

9.1 OVERVIEW

9.2 DYE-BASED REAGENTS

9.2.1 MASTER MIX

9.2.2 PRIMERS

9.2.3 DNA TEMPLATE

9.3 PROBE-BASED REAGENTS

9.3.1 MASTER MIX

9.3.2 PRIMERS

9.3.3 DNA TEMPLATE

10 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY ASSAY TYPE

10.1 OVERVIEW

10.2 QPCR SINGLEPLEX TEST/ASSAY

10.3 QPCR MULTIPLEX TEST/ASSAY

11 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY PLEXITY

11.1 OVERVIEW

11.2 DYE-BASED REAGENTS

11.2.1 SINGLEPLEX

11.2.2 MULTIPLEX

11.3 PROBE-BASED REAGENTS

11.3.1 SINGLEPLEX

11.3.2 MULTIPLEX

12 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE

12.1 OVERVIEW

12.2 KITS

12.3 MASTER MIXERS

13 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY TECHNOLOGY

13.1 OVERVIEW

13.2 GENE EXPRESSION

13.3 GENE TYPING

13.4 MIRNA ANALYSIS

13.5 PRE-AMPLIFICATION

13.6 VIRUS DETECTION

14 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY APPLICATION

14.1 OVERVIEW

14.2 RESEARCH

14.3 DIAGNOSTICS

14.4 FORENSIC

15 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY END USER

15.1 OVERVIEW

15.2 RESEARCH & ACADEMIC INSTITUTE

15.3 HOSPITAL AND DIAGNOSTIC CENTERS

15.4 CLINICAL RESEARCH ORGANIZATION

15.5 FORENSIC LABORATORIES

15.6 OTHERS

16 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL

16.1 OVERVIEW

16.2 DIRECT TENDER

16.3 THIRD PARTY DISTRIBUTORS

16.4 OTHERS

17 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY REGION

17.1 MIDDLE EAST AND AFRICA

17.1.1 SAUDI ARABIA

17.1.2 U.A.E

17.1.3 SOUTH AFRICA

17.1.4 ISRAEL

17.1.5 EGYPT

17.1.6 KUWAIT

17.1.7 REST OF MIDDLE EAST AND AFRICA

18 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: COMPANY LANDSCAPE

18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

19 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: SWOT ANALYSIS

20 COMPANY PROFILE

20.1 F. HOFFMANN-LA ROCHE LTD

20.1.1 COMPANY SNAPSHOT

20.1.2 REVENUE ANALYSIS

20.1.3 PRODUCT PORTFOLIO

20.1.4 RECENT DEVELOPMENT

20.2 MERCK KGAA

20.2.1 COMPANY SNAPSHOT

20.2.2 REVENUE ANALYSIS

20.2.3 PRODUCT PORTFOLIO

20.2.4 RECENT DEVELOPMENTS

20.2.4.1 PARTNERSHIP

20.2.4.2 NEW LABORATORY FACILITY

20.2.4.3 NEW DISTRIBUTION CENTER

20.3 THERMO FISHER SCIENTIFIC INC

20.3.1 COMPANY SNAPSHOT

20.3.2 REVENUE ANALYSIS

20.3.3 PRODUCT PORTFOLIO

20.3.4 RECENT DEVELOPMENTS

20.3.4.1 ACQUISITION

20.3.4.2 PRODUCT LAUNCH

20.4 AGILENT TECHNOLOGIES, INC

20.4.1 COMPANY SNAPSHOT

20.4.2 REVENUE ANALYSIS

20.4.3 PRODUCT PORTFOLIO

20.4.4 RECENT DEVELOPMENTS

20.4.4.1 DISTRIBUTION AGREEMENT

20.4.4.2 PRODUCT LAUNCH

20.5 SEEGENE INC.

20.5.1 COMPANY SNAPSHOT

20.5.2 PRODUCT PORTFOLIO

20.5.3 RECENT DEVELOPMENT

20.6 BIONEER CORPORATION

20.6.1 COMPANY SNAPSHOT

20.6.2 PRODUCT PORTFOLIO

20.6.3 RECENT DEVELOPMENT

20.7 BIO-RAD LABORATORIES, INC.

20.7.1 COMPANY SNAPSHOT

20.7.2 REVENUE ANALYSIS

20.7.3 PRODUCT PORTFOLIO

20.7.4 RECENT DEVELOPMENTS

20.7.4.1 PARTNERSHIP

20.7.4.2 AWARD

20.8 BIOTIUM

20.8.1 COMPANY SNAPSHOT

20.8.2 PRODUCT PORTFOLIO

20.8.3 RECENT DEVELOPMENTS

20.9 EMPIRICAL BIOSCIENCE, INC.

20.9.1 COMPANY SNAPSHOT

20.9.2 PRODUCT PORTFOLIO

20.9.3 RECENT DEVELOPMENTS

20.9.3.1 EUA AUTHORISATION

20.9.3.2 ISO CERTIFICATION

20.9.3.3 PRODUCT LAUNCH

20.1 ENZO BIOCHEM INC

20.10.1 COMPANY SNAPSHOT

20.10.2 REVENUE ANALYSIS

20.10.3 PRODUCT PORTFOLIO

20.10.4 RECENT DEVELOPMENT

20.11 GENEDIREX, INC

20.11.1 COMPANY SNAPSHOT

20.11.2 PRODUCT PORTFOLIO

20.11.3 RECENT DEVELOPMENT

20.12 KANEKA EUROGENTEC S.A

20.12.1 COMPANY SNAPSHOT

20.12.2 REVENUE ANALYSIS

20.12.3 PRODUCT PORTFOLIO

20.12.4 RECENT DEVELOPMENT

20.13 MIRXES PTE LTD

20.13.1 COMPANY SNAPSHOT

20.13.2 PRODUCT PORTFOLIO

20.13.3 RECENT DEVELOPMENT

20.14 NORGEN BIOTEK CORP

20.14.1 COMPANY SNAPSHOT

20.14.2 PRODUCT PORTFOLIO

20.14.3 RECENT DEVELOPMENT

20.15 NEW ENGLAND BIOLABS

20.15.1 COMPANY SNAPSHOT

20.15.2 PRODUCT PORTFOLIO

20.15.3 RECENT DEVELOPMENTS

20.15.3.1 AQUISITION

20.15.3.2 PRODUCT LAUNCH

20.15.3.3 SUBSIDIARY

20.16 PCR BIOSYSTEMS

20.16.1 COMPANY SNAPSHOT

20.16.2 PRODUCT PORTFOLIO

20.16.3 RECENT DEVELOPMENT

20.17 PROMEGA CORPORATION

20.17.1 COMPANY SNAPSHOT

20.17.2 PRODUCT PORTFOLIO

20.17.3 RECENT DEVELOPMENT

20.18 QIAGEN

20.18.1 COMPANY SNAPSHOT

20.18.2 REVENUE ANALYSIS

20.18.3 PRODUCT PORTFOLIO

20.18.4 RECENT DEVELOPMENTS

20.18.4.1 NEW FACILITY

20.18.4.2 ACQUISITION

20.19 QUANTABIO

20.19.1 COMPANY SNAPSHOT

20.19.2 PRODUCT PORTFOLIO

20.19.3 RECENT DEVELOPMENTS

20.19.3.1 CONFERENCE

20.19.3.2 PRODUCT LAUNCH

20.2 SINO BIOLOGICAL INC.

20.20.1 COMPANY SNAPSHOT

20.20.2 PRODUCT PORTFOLIO

20.20.3 RECENT DEVELOPMENT

20.21 SOLIS BIODYNE

20.21.1 COMPANY SNAPSHOT

20.21.2 PRODUCT PORTFOLIO

20.21.3 RECENT DEVELOPMENT

20.22 TAKARA HOLDINGS INC

20.22.1 COMPANY SNAPSHOT

20.22.2 REVENUE ANALYSIS

20.22.3 PRODUCT PORTFOLIO

20.22.4 RECENT DEVELOPMENTS

20.22.4.1 MANUFACTURING UNIT

20.22.4.2 ISO CERTIFICATION

20.23 TONBO BIOSCIENCES

20.23.1 COMPANY SNAPSHOT

20.23.2 PRODUCT PORTFOLIO

20.23.3 RECENT DEVELOPMENT

20.24 TRANSGENE BIOTEK LIMITED

20.24.1 COMPANY SNAPSHOT

20.24.2 REVENUE ANALYSIS

20.24.3 PRODUCT PORTFOLIO

20.24.4 RECENT DEVELOPMENT

20.25 YOUSEQ LTD

20.25.1 COMPANY SNAPSHOT

20.25.2 PRODUCT PORTFOLIO

20.25.3 RECENT DEVELOPMENT

21 QUESTIONNAIRE

22 RELATED REPORTS

표 목록

TABLE 1 HEALTHCARE EXPENDITURE IN ASIA-PACIFIC

TABLE 2 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST AND AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST AND AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST AND AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST AND AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST AND AFRICA QPCR SINGLEPLEX TEST/ASSAY IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST AND AFRICA QPCR MULTIPLEX TEST/ASSAY IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST AND AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST AND AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST AND AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST AND AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST AND AFRICA KITS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST AND AFRICA MASTER MIXERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST AND AFRICA GENE EXPRESSION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST AND AFRICA GENE TYPING IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST AND AFRICA MIRNA ANALYSIS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST AND AFRICA PRE-AMPLIFICATION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST AND AFRICA VIRUS DETECTION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST AND AFRICA GENE EXPRESSION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST AND AFRICA DIAGNOSTICS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST AND AFRICA FORENSIC IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST AND AFRICA RESEARCH & ACADEMIC INSTITUTE IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST AND AFRICA HOSPITAL AND DIAGNOSTIC CENTERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST AND AFRICA CLINICAL RESEARCH ORGANIZATION IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST AND AFRICA FORENSIC LABORATORIES IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST AND AFRICA OTHERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST AND AFRICA DIRECT TENDER IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTORS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST AND AFRICA OTHERS IN Q-PCR REAGENTS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST AND AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST AND AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST AND AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST AND AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 50 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 51 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 52 SAUDI ARABIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 53 SAUDI ARABIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 54 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 55 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 56 SAUDI ARABIA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 57 SAUDI ARABIA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 58 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 59 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 60 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 61 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 62 SAUDI ARABIA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 63 U.A.E Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 64 U.A.E DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 65 U.A.E PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 66 U.A.E Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 67 U.A.E Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 68 U.A.E DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 69 U.A.E PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 70 U.A.E Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 71 U.A.E Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 72 U.A.E Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 73 U.A.E Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 74 U.A.E Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 75 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 76 SOUTH AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 77 SOUTH AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 78 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 79 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 80 SOUTH AFRICA DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 81 SOUTH AFRICA PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 82 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 83 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 84 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 85 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 86 SOUTH AFRICA Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 87 ISRAEL Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 88 ISRAEL DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 89 ISRAEL PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 90 ISRAEL Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 91 ISRAEL Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 92 ISRAEL DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 93 ISRAEL PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 94 ISRAEL Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 95 ISRAEL Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 96 ISRAEL Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 97 ISRAEL Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 98 ISRAEL Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 99 EGYPT Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 100 EGYPT DYE-BASED REAGENTS Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 101 EGYPT PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 102 EGYPT Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 103 EGYPT Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 104 EGYPT DYE-BASED REAGENTS Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 105 EGYPT PROBE-BASED REAGENTS Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 106 EGYPT Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 107 EGYPT Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 108 EGYPT Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 EGYPT Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 110 EGYPT Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 111 KUWAIT Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

TABLE 112 KUWAIT DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 113 KUWAIT PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PRODUCT, 2020-2029 (USD MILLION)

TABLE 114 KUWAIT Q-PCR REAGENTS MARKET, BY ASSAY TYPE, 2020-2029 (USD MILLION)

TABLE 115 KUWAIT Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 116 KUWAIT DYE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 117 KUWAIT PROBE-BASED REAGENTS IN Q-PCR REAGENTS MARKET, BY PLEXITY, 2020-2029 (USD MILLION)

TABLE 118 KUWAIT Q-PCR REAGENTS MARKET, BY PACKAGING TYPE, 2020-2029 (USD MILLION)

TABLE 119 KUWAIT Q-PCR REAGENTS MARKET, BY TECHNOLOGY, 2020-2029 (USD MILLION)

TABLE 120 KUWAIT Q-PCR REAGENTS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 121 KUWAIT Q-PCR REAGENTS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 122 KUWAIT Q-PCR REAGENTS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 123 REST OF MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET, BY DETECTION TYPE, 2020-2029 (USD MILLION)

그림 목록

FIGURE 1 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET : DATA TRIANGULATION

FIGURE 3 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: DROC ANALYSIS

FIGURE 4 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: DBMR MARKET POSITION GRID

FIGURE 8 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: APPLICATION COVERAGE GRID

FIGURE 9 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: SEGMENTATION

FIGURE 11 INCREASE IN DEMAND FOR Q-PCR REAGENTS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 12 MODERATE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET IN 2022 & 2029

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF Q-PCRREAGENTS MARKET

FIGURE 14 PREVALENCE OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) IN WORLD HEALTH ORGANISATION (WHO) REGIONS IN 2020

FIGURE 15 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, 2021

FIGURE 16 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, 2020-2029 (USD MILLION)

FIGURE 17 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, CAGR (2022-2029)

FIGURE 18 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE, LIFELINE CURVE

FIGURE 19 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, 2021

FIGURE 20 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, 2020-2029 (USD MILLION)

FIGURE 21 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, CAGR (2022-2029)

FIGURE 22 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY ASSAY TYPE, LIFELINE CURVE

FIGURE 23 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PLEXITY, 2021

FIGURE 24 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PLEXITY, 2020-2029 (USD MILLION)

FIGURE 25 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PLEXITY, CAGR (2022-2029)

FIGURE 26 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PLEXITY, LIFELINE CURVE

FIGURE 27 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, 2021

FIGURE 28 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, 2020-2029 (USD MILLION)

FIGURE 29 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, CAGR (2022-2029)

FIGURE 30 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY PACKAGING TYPE, LIFELINE CURVE

FIGURE 31 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, 2021

FIGURE 32 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, 2020-2029 (USD MILLION)

FIGURE 33 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, CAGR (2022-2029)

FIGURE 34 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY TECHNOLOGY, LIFELINE CURVE

FIGURE 35 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY APPLICATION, 2021

FIGURE 36 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY APPLICATION, 2020-2029 (USD MILLION)

FIGURE 37 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 38 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 39 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY END USER, 2021

FIGURE 40 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY END USER, 2020-2029 (USD MILLION)

FIGURE 41 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 42 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY END USER, LIFELINE CURVE

FIGURE 43 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 44 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

FIGURE 45 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 46 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 47 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: SNAPSHOT (2021)

FIGURE 48 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY COUNTRY (2021)

FIGURE 49 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 50 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 51 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: BY DETECTION TYPE (2022-2029)

FIGURE 52 MIDDLE EAST AND AFRICA Q-PCR REAGENTS MARKET: COMPANY SHARE 2021 (%)

자세한 정보 보기 Right Arrow

연구 방법론

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.

DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.

사용자 정의 가능

Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.